Iceland· IS-EU/1/98/095/001-002

Emadine

A emedastine product containing emedastinum inn dífúmarat, registered in Iceland by Immedica Pharma AB. The same ATC class is registered in 12 of our 19 countries.

ATC S01GX06

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedEmadineATCS01GX06REGISTER NO.IS-EU/1/98/095/001-002PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Emedastine is registered in 12 of 19 countries.

Countries holding a registration under ATC S01GX06 (emedastine), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Emedastine · ATC S01GX06

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Emedastinum INN dífúmarat
Manufacturer
Immedica Pharma AB
Country
Iceland (IS)
ATC code
S01GX06
ATC class
Emedastine
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/44a212d9-b228-497d-bf91-5e98a66870db
GET /v1/drugs/44a212d9-b228-497d-bf91-5e98a66870db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Augndropar, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "S01GX06",
  "marketed": true,
  "strength": "0,5 mg/ml",
  "ma_number": "EU/1/98/095/001-002",
  "substance": "Emedastinum INN dífúmarat",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "36973"
}

See everything about emedastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.